Lactate dehydrogenase C (LDHC, LDHX, CT32) is a CTA that has been shown to be aberrantly expressed in several solid cancers, including breast, lung, renal and colon cancer, and exhibits immunogenic properties [8, 10]. Here, LDHC is linked to colonic neoplasm.